Acquisition of Porgès Laboratories by Mentor Corporation
+
Acquisition of Mentor Corporation by Coloplast


Mentor Acquires Leading French Urology Company

Friday February 9, 2001, 8:01 am Eastern Time

SOURCE: Mentor Corporation
Mentor Acquires Leading French Urology Company
SANTA BARBARA, Calif., Feb. 9 /PRNewswire/ -- Mentor Corporation (Nasdaq: MNTR - news) announced today that it has completed the acquisition of Porges S.A., a subsidiary of Sanofi-Synthelabo. The transaction was valued at EUR 35 million, or about $32 million.
Porges is a manufacturer of urological products, supplying a complete range of products for the urological surgeon, including diagnostic tools and various devices for surgery and for postoperative follow-up. Porges holds the leading market share for urological products in France and has a strong position throughout Europe. The company's sales last year were EUR 46 million, or about $42 million.
Porges has headquarters in Paris, with manufacturing facilities in Sarlat, France, and marketing subsidiaries in eight countries in Europe, plus one in Japan.
``I am very excited about this acquisition,'' said Christopher J. Conway, president of Mentor. ``We believe that Porges and Mentor will be a powerful combination in the global urology market. Our product lines are complementary and together we have the broadest and most advanced line of urological products in the world. Our combined sales of products in this market exceed $150 million.
``The opportunities for growth with our shared technologies and markets are considerable,'' Conway said. ``Porges provides an ideal platform for the European launch of new Mentor products like the Suspend® incontinence implant and our brachytherapy line. Likewise, Mentor will begin actively marketing the Porges product line, which is not currently distributed in the U.S.''
With sales of EUR 6 billion in 2000 and 29,000 employees in more than 100 countries, Sanofi-Synthelabo ranks among the world's top 20 pharmaceutical companies.
Mentor Corporation develops and manufactures specialized medical products, which it markets throughout the world. This release contains, in addition to historical information, forward-looking statements. Such statements are based on management's current expectations and are subject to a number of uncertainties and risks that could cause actual results to differ materially from those described in the forward-looking statements. Factors that may cause such a difference include, but are not limited to, those described in the Company's Annual Report on Form 10-K for the fiscal year ended March 31, 2000.
SOURCE: Mentor Corporation


Porgès, the medical devices subsidiary of Sanofi-Synthélabo in urology, sold to Mentor Corporation

Paris, February 09, 2001
Sanofi-Synthélabo announced today that it has sold 100% of the shares of Porgès, its medical devices subsidiary in urology, to Mentor Corporation.
The transaction is valued at 35 million €uros.
Porgès is a manufacturer of urological products, and supplies a complete range of products meeting the urology surgeon’s requirements, including diagnostic tools (biopsy needles) and various devices for surgery and postoperative follow-up (prostatic catheters).
Porgès has subsidiaries in 8 countries in Europe and one in Japan, a manufacturing facility in Sarlat, France, and a distribution center in Palaiseau, France.
In 2000, Porgès sales figure reached 46 million €uros.
Mentor Corporation develops, manufactures and markets specialized medical products, such as surgically implantable devices, surgical equipment and disposable medical and surgical supplies. The Company’s executive and sales offices are located in Santa Barbara, California, with manufacturing and research operations in Minnesota, Texas, and The Netherlands.
With Sales of 6 billion €uros in 2000 and 29,000 employees in more than 100 countries, Sanofi-Synthélabo ranks among the world’s top 20 pharmaceutical companies. Sanofi-Synthélabo is focused on a core group of four therapeutic areas : cardiovascular disease/thrombosis, central nervous system, internal medicine and oncology; this enables the Group to be a significant player in each of these areas.

If you are looking for the site of Porges Laboratories France (A Mentor Company),

 


In 2006, Mentor was acquired by Coloplast.

Press release

 

In 2017, Porges is a division of Coloplast click here

 

Return to Porgès Laboratories main page